GlassScriptPhysician profile
Leanne Harker
NPI 1457594905
$2,790.24
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $873 · 2022: $1,015 · 2023: $348 · 2024: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $398.11 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $373.18 | 2021-2024 | Zepbound, Mounjaro, Jardiance |
| Axsome Therapeutics, INC. | $211.78 | 2023-2024 | Auvelity, Sunosi |
| Novartis Pharmaceuticals Corporation | $198.92 | 2022-2024 | |
| Welch Allyn | $191.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.57 | 2021-2024 | Jardiance |
| Pfizer INC. | $124.80 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.43 | 2021-2024 | |
| Amgen INC. | $102.01 | 2021-2024 | Prolia, Evenity, Repatha |
| Grt US Holding, INC. | $96.15 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $77.64 | 2022 | |
| Abbott Laboratories | $71.99 | 2021-2023 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $57.65 | 2021-2022 | |
| Daiichi Sankyo INC. | $48.51 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $46.49 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Harker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.